Menu

Blog

Archive for the ‘genetics’ category: Page 290

Jul 1, 2020

Could you become a ‘natural’ blonde

Posted by in categories: biotech/medical, genetics

The Kingsley team pored over genetic data repositories, searching for places in the genetic code near the KITLG gene that tell the gene what to do. They found a location in the DNA where proteins known as transcription factors bind to the sequence and carry out the instructions specified in the code.

They discovered that if the nucleotide guanine holds that spot, the transcription factor cannot bind as tightly to the DNA as when another nucleotide (adenine) is in the same position. This simple alteration – replacing A with G in the DNA sequence – reduces the expression of the gene and, ultimately, changes the colour of the hair.

Guenther’s blue-flecked mice prove that the Kingsley group found the spot on the genome that informs hair follicles how much melanin to incorporate into hair.

Jul 1, 2020

Pilot Study Results Suggest Epigenetic Age Reversal

Posted by in categories: genetics, life extension

3 things:

1. The company claims that it has been successful in reducing the epigenetic age of participants(17 people) by an average of 8.5 years with its dietary supplement Rejuvant.

2. Obviously, this has yet to be proven conclusively in human trials, and the company is busy preparing to launch a larger-scale trial later this year to that end.

Continue reading “Pilot Study Results Suggest Epigenetic Age Reversal” »

Jun 29, 2020

When two are better than one: Why some gene duplicates are retained while others perish

Posted by in categories: biotech/medical, genetics

Whole genome duplication followed by massive gene loss has shaped many genomes, including the human genome. Why some gene duplicates are retained while most perish has puzzled scientists for decades.

A study, published today in Science, has found that gene retention depends on the degree of “functional and structural entanglement”, which measures interdependency between gene structure and function. In other words, while most duplicates either become obsolete or they evolve new roles, some are retained forever because, evolutionarily speaking, they’re simply stuck.

“When we scan genomes there are some gene pairs that remain from events that occurred millions of years ago,” says Elena Kuzmin, a co-lead author of the study and former graduate student who trained with Charles Boone, professor of molecular genetics in the Donnelly Centre for Cellular and Biomolecular Research, at the University of Toronto, who co-led the study.

Jun 29, 2020

Circular RNA found to make fruit flies live longer

Posted by in categories: biological, genetics, life extension, neuroscience

Ribonucleic acid, or RNA, is part of our genetic code and present in every cell of our body. The best known form of RNA is a single linear strand, of which the function is well known and characterized. But there is also another type of RNA, so-called “circular RNA,” or circRNA, which forms a continuous loop that makes it more stable and less vulnerable to degradation. CircRNAs accumulate in the brain with age. Still, the biological functions of most circRNAs are not known and are a riddle for the scientific community. Now scientists from the Max Planck Institute for Biology of Aging have come one step closer to answer the question what these mysterious circRNAs do: one of them contributes to the aging process in fruit flies.

Carina Weigelt and other researchers in the group led by Linda Partridge, Director at the Max Planck Institute for Biology of Aging, used to investigate the role of the circRNAs in the aging process. “This is unique, because it is not very well understood what circRNAs do, especially not in an aging perspective. Nobody has looked at circRNAs in a longevity context before,” says Carina Weigelt who conducted the main part of the study. She continues: “Now we have identified a circRNA that can extend lifespan of fruit flies when we increase it, and it is regulated by signaling.”

Jun 28, 2020

A ‘Cure for Heart Disease’? A Single Shot Succeeds in Monkeys

Posted by in categories: biotech/medical, genetics

A novel gene-editing experiment seems to have permanently reduced LDL and triglyceride levels in monkeys.

Jun 27, 2020

GloWGR Introduction and How to Accelerate Genetic mixed models for genetics with whole genome regression in Glow

Posted by in categories: biotech/medical, genetics

Learn how Databricks and the Regeneron Genetics Center partnered to introduce whole genome regression into Project Glow, reducing the cost of fitting mixed models on genetics datasets by orders of magnitude.

Jun 26, 2020

Dynamics of DNA replication revealed at the nanoscale

Posted by in categories: biotech/medical, genetics, nanotechnology

DNA replication is a process of critical importance to the cell, and must be coordinated precisely to ensure that genomic information is duplicated once and only once during each cell cycle. Using super-resolution technology a University of Technology Sydney led team has directly visualized the process of DNA replication in single human cells.

This is the first quantitative characterization to date of the spatio-temporal organization, morphology, and in situ epigenetic signatures of individual replication foci (RFi) in single human at the nanoscale.

The results of the study, published in PNAS (Proceedings of the National Academy of Sciences) give new insight into a poorly understood area of DNA replication namely how replication origin sites are chosen from thousands of possible sites.

Jun 25, 2020

From Jekyll to Hyde: Genetic Mutation That Makes E. Coli Deadlier Pinpointed

Posted by in categories: biotech/medical, evolution, genetics

Scientists identify an important protein that increases “bacterial virulence,” when mutated, changing harmless bacteria to harmful ones.

As far as humans are concerned, bacteria can be classified as either harmful, pathogenic bacteria and harmless or beneficial non-pathogenic bacteria. To develop better treatments for diseases caused by pathogenic bacteria, we need to have a good grasp on the mechanisms that cause some bacteria to be virulent. Scientists have identified genes that cause virulence, or capability to cause disease, but they do not fully know how bacteria evolve to become pathogenic.

To find out, Professor Chikara Kaito and his team of scientists from Okayama University, Japan, used a process called experimental evolution to identify molecular mechanisms that cells develop to gain useful traits, and published their findings in PLoS Pathogens. “We’re excited by this research because no one has ever looked at virulence evolution of bacteria in an animal; studies before us looked at the evolution in cells,” said Prof Kaito.

Jun 24, 2020

One-Time Treatment Generates New Neurons, Eliminates Parkinson’s Disease in Mice

Posted by in categories: biotech/medical, genetics, neuroscience

Xiang-Dong Fu, PhD, has never been more excited about something in his entire career. He has long studied the basic biology of RNA, a genetic cousin of DNA, and the proteins that bind it. But a single discovery has launched Fu into a completely new field: neuroscience.

For decades, Fu and his team at University of California San Diego School of Medicine studied a protein called PTB, which is well known for binding RNA and influencing which genes are turned “on” or “off” in a cell. To study the role of a protein like PTB, scientists often manipulate cells to reduce the amount of that protein, and then watch to see what happens.


But then he noticed something odd after a couple of weeks — there were very few fibroblasts left. Almost the whole dish was instead filled with neurons.

Continue reading “One-Time Treatment Generates New Neurons, Eliminates Parkinson’s Disease in Mice” »

Jun 24, 2020

Massive genomic database helps decode mutations’ effects

Posted by in categories: biotech/medical, genetics, neuroscience

A trove of DNA sequences from 141,456 people — and counting — offers researchers an unparalleled look at genetic variation across the general population1,2. The resource has been helping researchers to identify variants that contribute to autism since it was released online about four years ago3,4.

The genomes of autistic people harbor hundreds of potentially harmful mutations. But to firmly connect a specific variant to the condition, researchers need to see if it is common among typical people — a sign that that variant may actually be benign.

In 2014, researchers debuted one of the first tools to probe the prevalence of a mutation in the general population. Known as the Exome Aggregation Consortium (ExAC), it contained 60,000 sequences of exomes — the protein-coding regions of the genome5.